How to Buy Plus Therapeutics Stock
Plus Therapeutics Inc
Plus Therapeutics, Inc. , a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases.
Plus Therapeutics stock last closed at $0.64, down 2.73% from the previous day, and has decreased 61.39% in one year. It has overperformed other stocks in the Biotechnology industry by 0.16 percentage points. Plus Therapeutics stock is currently +167.08% from its 52-week low of $0.24, and -75.99% from its 52-week high of $2.67.
At the moment, there are 17M PSTV shares outstanding. The market capitalization of PSTV is $10.90M. In the last 24 hours, 504,526 PSTV shares were traded.
How to Buy Plus Therapeutics Stock
Wondering how to invest in Plus Therapeutics stock? Here's how.
- Decide where to buy Plus Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Plus Therapeutics stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your method of payment and add your info.
- Evaluate Plus Therapeutics stock: The Plus Therapeutics ticker symbol is PSTV. Is Plus Therapeutics stock a good investment? Should you buy shares of PSTV? How do PSTV's underlying business fundamentals look? Do top analysts think Plus Therapeutics is a good buy? Why has PSTV's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PSTV is a good stock to buy).
- Execute your PSTV trade: Decide if you will purchase PSTV shares at the current market price or use a limit order to purchase PSTV stock at a given price.
- Get notifications regarding your PSTV investment: Create a watchlist to track your new investment in Plus Therapeutics stock.
Step 1: Decide where to buy Plus Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy PSTV stock.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal details so you can invest in PSTV today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start your new brokerage account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the greatest app to buy stocks, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring money into your new investment account.
Step 4: Evaluate Plus Therapeutics stock
Once you have decided on the best place to buy Plus Therapeutics stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk and upside.
Plus Therapeutics quick stats
PSTV Fundamentals
WallStreetZen was designed to help part-time investors perform better fundamental analysis in less time.
You can see all of the due diligence checks on PSTV's stock page.
Is PSTV stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge PSTV's intrinsic value.
You can do additional valuation research on PSTV's stock here.
PSTV Financial Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the PSTV balance sheet.
Failed Financial Due Diligence Checks:
- PSTV profit margin has gone up by 0.48 percentage points in the past year, but the company is still unprofitable.
- PSTV has cash burn of 10700000. It does not have sufficient cash and short-term investments to cover this.
- Total PSTV debt is still negative.
- PSTV has $3.61M in cash and short term investments. This is not enough to cover its annual cash burn of $10.70M.
- There are more short-term liabilities than short-term assets on the PSTV balance sheet.
- PSTV debt to equity ratio of -1.74 is negative.
Is Plus Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 3 Equities analysts who give recommendations on PSTV, the consensus analyst rating on PSTV is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Plus Therapeutics stock forecast page.
PSTV Momentum
PSTV Revenue
Last year, PSTV revenue was $5.82M. In the past 5 year, PSTV's revenue has increased by -3.61% per year. This was slower than the Biotechnology industry average of 44.31%.
You can research PSTV's earnings and revenue performance here.
What are PSTV executives and large shareholders up to?
Over the past 12 months, executives and large shareholders at PSTV have bought more shares than they have sold.
Richard J. Hawkins, Director of PSTV, was the latest PSTV insider to buy. They bought $5,996.00 worth of PSTV shares on Sep 13, 2024.
Learn more about who owns PSTV shares here.
Does PSTV provide a stable income stream?
No, Plus Therapeutics doesn't provide an income stream by paying out dividends.
PSTV Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your PSTV trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price limit, place a limit order.
Click the Open Trade button and eToro will execute the order.
If you want more info about buying stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your PSTV investment
Now that you own some shares in PSTV, you'll want to stay up-to-date on your new stock purchase.
Make a watchlist to track the most important metrics related to your PSTV stock.
PSTV Feed
How to Buy Stock in Plus Therapeutics
To reiterate, here are the 6 steps you need to take to buy Plus Therapeutics stock right now:
- Decide where to buy Plus Therapeutics stock
- Create a brokerage account
- Deposit funds into your brokerage account
- Evaluate Plus Therapeutics stock
- Execute your PSTV trade
- Get notifications regarding your PSTV investment
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Plus Therapeutics, hit the button below to create your watchlist.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.